$459 Million is the total value of Cheviot Value Management, LLC's 75 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FB | Sell | Meta Platforms, Inc. | $13,731,706 | +1249.6% | 47,849 | -0.3% | 2.99% | +1120.8% |
QQQ | Sell | Invesco Qqq Trust | $4,898,663 | +12.9% | 13,260 | -1.9% | 1.07% | +2.2% |
PAAS | Sell | Pan American Silver Corp | $3,923,872 | -23.0% | 269,127 | -3.8% | 0.86% | -30.2% |
ABT | Sell | Abbott Laboratories | $1,953,220 | +6.0% | 17,916 | -1.5% | 0.42% | -4.1% |
GDX | Sell | Vaneck Vectors Gold Miners | $1,908,101 | -7.3% | 63,371 | -0.4% | 0.42% | -16.0% |
DIS | Sell | Walt Disney Co | $1,150,778 | -24.2% | 12,890 | -14.9% | 0.25% | -31.2% |
AMAT | Sell | Applied Materials | $802,342 | +15.6% | 5,551 | -1.8% | 0.18% | +4.8% |
AGI | Sell | Alamos Gold Inc | $607,050 | -15.1% | 50,927 | -12.9% | 0.13% | -23.3% |
NVDA | Sell | Nvidia Corp Com | $493,244 | +47.2% | 1,166 | -3.3% | 0.11% | +32.1% |
BMY | Sell | Bristol-Myers Squibb | $414,524 | -11.2% | 6,482 | -3.7% | 0.09% | -19.6% |
MA | Sell | Mastercard Inc Class A | $406,672 | +7.8% | 1,034 | -0.4% | 0.09% | -2.2% |
HD | Sell | Home Depot Inc | $371,836 | +5.0% | 1,197 | -0.2% | 0.08% | -4.7% |
SPY | Sell | Spdr S&p 500 | $320,070 | -1.1% | 722 | -8.6% | 0.07% | -10.3% |
CSCO | Sell | Cisco Systems Inc | $302,008 | -1.5% | 5,837 | -0.5% | 0.07% | -10.8% |
BA | Sell | Boeing Co | $278,098 | -2.8% | 1,317 | -2.2% | 0.06% | -11.6% |
GOOG | Sell | Alphabet Inc Cl C | $267,102 | -7.9% | 2,208 | -20.8% | 0.06% | -17.1% |
NGD | Sell | New Gold Inc F | $23,312 | -10.1% | 21,585 | -8.5% | 0.01% | -16.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-07
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Berkshire Hathaway-B | 43 | Q3 2023 | 20.4% |
Johnson & Johnson | 43 | Q3 2023 | 8.0% |
Microsoft Corp | 43 | Q3 2023 | 7.2% |
Newmont Mining Corp | 43 | Q3 2023 | 11.4% |
Pfizer Incorporated | 43 | Q3 2023 | 4.8% |
Agnico-Eagle Mines Ltd | 43 | Q3 2023 | 6.3% |
Pan American Silver Corp | 43 | Q3 2023 | 4.3% |
Merck & Co. Inc. | 43 | Q3 2023 | 3.2% |
AbbVie Inc | 43 | Q3 2023 | 3.0% |
Markel Corp Holding Company | 43 | Q3 2023 | 2.5% |
View Cheviot Value Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-07 |
13F-HR | 2023-11-07 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-03 |
13F-HR | 2022-05-11 |
13F-HR | 2022-02-14 |
View Cheviot Value Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.